Federal Circuit Denies Ariad's Request
In yet another setback for Ariad Pharmaceuticals Inc., a federal appeals court has rejected the drug maker's request to hear an early appeal of a pretrial ruling in the patent infringement...To view the full article, register now.
Already a subscriber? Click here to view full article